These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34410179)

  • 1. Cortical involvement and leptomeningeal inflammation in myelin oligodendrocyte glycoprotein antibody disease: A three-dimensional fluid-attenuated inversion recovery MRI study.
    Tzanetakos D; Tzartos JS; Vakrakou AG; Breza M; Velonakis G; Stathopoulos P; Pantou E; Markakis I; Papadimitriou D; Karavasilis E; Toulas P; Evangelopoulos ΜE; Koutsis G; Anagnostouli M; Stefanis L; Kilidireas C
    Mult Scler; 2022 Apr; 28(5):718-729. PubMed ID: 34410179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of leptomeningeal inflammation in rodent experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis.
    Pol S; Schweser F; Bertolino N; Preda M; Sveinsson M; Sudyn M; Babek N; Zivadinov R
    Exp Neurol; 2019 Apr; 314():82-90. PubMed ID: 30684521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images.
    Li L; Liu W; Cai Q; Liu Y; Hu W; Zuo Z; Ma Q; He S; Jin K
    Front Immunol; 2023; 14():1152235. PubMed ID: 37409120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptomeningeal Enhancement on 3D-FLAIR MRI in Multiple Sclerosis: Systematic Observations in Clinical Practice.
    Titelbaum DS; Engisch R; Schwartz ED; Napoli SQ; Sloane JA; Samaan S; Katz JD; Lathi ES
    J Neuroimaging; 2020 Nov; 30(6):917-929. PubMed ID: 32830899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions.
    Zurawski J; Tauhid S; Chu R; Khalid F; Healy BC; Weiner HL; Bakshi R
    Mult Scler; 2020 Feb; 26(2):177-187. PubMed ID: 31714181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis.
    Zivadinov R; Ramasamy DP; Hagemeier J; Kolb C; Bergsland N; Schweser F; Dwyer MG; Weinstock-Guttman B; Hojnacki D
    AJNR Am J Neuroradiol; 2018 Apr; 39(4):642-647. PubMed ID: 29439125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica.
    Ciotti JR; Eby NS; Brier MR; Wu GF; Chahin S; Cross AH; Naismith RT
    Mult Scler; 2022 Jan; 28(1):49-60. PubMed ID: 33870786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis.
    Hildesheim FE; Ramasamy DP; Bergsland N; Jakimovski D; Dwyer MG; Hojnacki D; Lizarraga AA; Kolb C; Eckert S; Weinstock-Guttman B; Zivadinov R
    Mult Scler Relat Disord; 2021 Jan; 47():102653. PubMed ID: 33333417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MOG antibody associated disease (MOGAD) presenting with extensive brain stem encephalitis: A case report.
    Olbert E; Brunner C; Alhani N; Našel C; Struhal W
    eNeurologicalSci; 2022 Dec; 29():100432. PubMed ID: 36388768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.
    Absinta M; Vuolo L; Rao A; Nair G; Sati P; Cortese IC; Ohayon J; Fenton K; Reyes-Mantilla MI; Maric D; Calabresi PA; Butman JA; Pardo CA; Reich DS
    Neurology; 2015 Jul; 85(1):18-28. PubMed ID: 25888557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study.
    Zivadinov R; Ramasamy DP; Vaneckova M; Gandhi S; Chandra A; Hagemeier J; Bergsland N; Polak P; Benedict RH; Hojnacki D; Weinstock-Guttman B
    Mult Scler; 2017 Sep; 23(10):1336-1345. PubMed ID: 27811339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central Vein Sign in Pediatric Multiple Sclerosis and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
    Harrison KL; Gaudioso C; Levasseur VA; Dunham SR; Schanzer N; Keuchel C; Salter A; Goyal MS; Mar S
    Pediatr Neurol; 2023 Sep; 146():21-25. PubMed ID: 37406422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Multiple Sclerosis Cortical Lesion Types Detected by Multicontrast 3T and 7T MRI.
    Maranzano J; Dadar M; Rudko DA; De Nigris D; Elliott C; Gati JS; Morrow SA; Menon RS; Collins DL; Arnold DL; Narayanan S
    AJNR Am J Neuroradiol; 2019 Jul; 40(7):1162-1169. PubMed ID: 31221631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder.
    Camera V; Holm-Mercer L; Ali AAH; Messina S; Horvat T; Kuker W; Leite MI; Palace J
    JAMA Netw Open; 2021 Dec; 4(12):e2137833. PubMed ID: 34878547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of brain MRI lesions in paediatric myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and its relevance to disease course.
    Abdel-Mannan O; Champsas D; Tur C; Lee V; Manivannan S; Usman H; Skippen A; Desai I; Chitre M; Forsyth R; Kneen R; Ram D; Ramdas S; Rossor T; West S; Wright S; Palace J; Wassmer E; Hemingway C; Lim MJ; Mankad K; Ciccarelli O; Hacohen Y;
    J Neurol Neurosurg Psychiatry; 2024 Apr; 95(5):426-433. PubMed ID: 37979966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly Sensitive 3-Tesla Real Inversion Recovery MRI Detects Leptomeningeal Contrast Enhancement in Chronic Active Multiple Sclerosis.
    Okar SV; Dieckhaus H; Beck ES; Gaitán MI; Norato G; Pham DL; Absinta M; Cortese IC; Fletcher A; Jacobson S; Nair G; Reich DS
    Invest Radiol; 2024 Mar; 59(3):243-251. PubMed ID: 37493285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study.
    Bergsland N; Ramasamy D; Tavazzi E; Hojnacki D; Weinstock-Guttman B; Zivadinov R
    AJNR Am J Neuroradiol; 2019 Apr; 40(4):620-625. PubMed ID: 30872420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified models to distinguish central nervous system demyelinating diseases with brain lesions.
    Chen B; Qin C; Ji S; Tian D; Zhang M; Bu B
    Mult Scler Relat Disord; 2021 Jul; 52():102965. PubMed ID: 33905981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningo-cortical manifestations of myelin oligodendrocyte glycoprotein antibody-associated disease: Review of a novel clinico-radiographic spectrum.
    Budhram A; Mirian A; Sharma M
    Front Neurol; 2022; 13():1044642. PubMed ID: 36341089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease.
    Sacco S; Virupakshaiah A; Papinutto N; Schoeps VA; Akula A; Zhao H; Arona J; Stern WA; Chong J; Hart J; Zamvil SS; Sati P; Henry RG; Waubant E
    Mult Scler; 2023 Dec; 29(14):1736-1747. PubMed ID: 37897254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.